Group One Trading, L.P. Zynerba Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.4 - $0.67 $600 - $1,005	-1,500 Reduced 24.76%	4,559 $1,000
Q4 2022 Feb 09, 2023	BUY	$0.5 - $0.72 $522 - $752	1,045 Added 20.84%	6,059 $3,000
Q3 2022 Nov 09, 2022	SELL	$0.87 - $1.36 $10,005 - $15,640	-11,500 Reduced 69.64%	5,014 $4,000
Q2 2022 Aug 11, 2022	SELL	$0.86 - $2.06 $10,062 - $24,102	-11,700 Reduced 41.47%	16,514 $19,000
Q1 2022 May 12, 2022	SELL	$1.83 - $3.02 $71,789 - $118,471	-39,229 Reduced 58.17%	28,214 $58,000
Q4 2021 Feb 11, 2022	SELL	$2.88 - $4.3 $5,431 - $8,109	-1,886 Reduced 2.72%	67,443 $194,000
Q3 2021 Nov 12, 2021	SELL	$3.72 - $5.35 $160,640 - $231,029	-43,183 Reduced 38.38%	69,329 $294,000
Q2 2021 Aug 10, 2021	BUY	$3.83 - $5.98 $310,888 - $485,408	81,172 Added 259.0%	112,512 $595,000
Q1 2021 May 12, 2021	BUY	$3.33 - $8.76 $77,958 - $205,080	23,411 Added 295.26%	31,340 $146,000
Q4 2020 Feb 10, 2021	SELL	$3.27 - $4.64 $109,440 - $155,291	-33,468 Reduced 80.85%	7,929 $26,000
Q3 2020 Nov 12, 2020	BUY	$3.23 - $4.3 $133,712 - $178,007	41,397 New	41,397 $137,000
Q2 2020 Aug 13, 2020	SELL	$3.31 - $6.54 $74,296 - $146,796	-22,446 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.9 - $6.16 $33,318 - $70,772	11,489 Added 104.86%	22,446 $86,000
Q4 2019 Feb 10, 2020	SELL	$5.61 - $8.57 $193,449 - $295,519	-34,483 Reduced 75.89%	10,957 $66,000
Q3 2019 Nov 12, 2019	SELL	$7.56 - $15.44 $499,632 - $1.02 Million	-66,089 Reduced 59.26%	45,440 $344,000
Q2 2019 Aug 09, 2019	BUY	$5.4 - $15.5 $396,095 - $1.14 Million	73,351 Added 192.13%	111,529 $1.51 Million
Q1 2019 May 13, 2019	SELL	$3.6 - $6.22 $1,929 - $3,333	-536 Reduced 1.38%	38,178 $207,000
Q4 2018 Feb 06, 2019	SELL	$2.89 - $7.91 $29,160 - $79,811	-10,090 Reduced 20.67%	38,714 $115,000
Q3 2018 Nov 08, 2018	BUY	$5.59 - $10.45 $178,477 - $333,647	31,928 Added 189.19%	48,804 $398,000
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $155,282 - $241,097	-19,459 Reduced 53.55%	16,876 $164,000
Q1 2018 May 11, 2018	BUY	$8.49 - $13.46 $308,484 - $489,069	36,335 New	36,335 $316,000
Q3 2017 Nov 15, 2017	SELL	$5.73 - $9.44 $26,335 - $43,386	-4,596 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	4,596	4,596 $78,000

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account